Cargando…

Multi-Omics Approaches for the Prediction of Clinical Endpoints after Immunotherapy in Non-Small Cell Lung Cancer: A Comprehensive Review

Immune checkpoint inhibitors (ICI) have revolutionized the management of locally advanced and advanced non-small lung cancer (NSCLC). With an improvement in the overall survival (OS) as both first- and second-line treatments, ICIs, and especially programmed-death 1 (PD-1) and programmed-death ligand...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bourbonne, Vincent, Geier, Margaux, Schick, Ulrike, Lucia, François
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9219996/ https://www.ncbi.nlm.nih.gov/pubmed/35740259 http://dx.doi.org/10.3390/biomedicines10061237

Ejemplares similares

Narrative Review of Synergistics Effects of Combining Immunotherapy and Stereotactic Radiation Therapy
por: Lucia, François, et al.
Publicado: (2022)

Combination of Radiomics Features and Functional Radiosensitivity Enhances Prediction of Acute Pulmonary Toxicity in a Prospective Validation Cohort of Patients with a Locally Advanced Lung Cancer Treated with VMAT-Radiotherapy
por: Bourbonne, Vincent, et al.
Publicado: (2022)

Toxicity after volumetric modulated arc therapy for lung cancer: a monocentric retrospective study
por: Bourbonne, Vincent, et al.
Publicado: (2021)

Multi-omics integration for neuroblastoma clinical endpoint prediction
por: Francescatto, Margherita, et al.
Publicado: (2018)

VMAT-Based Planning Allows Sparing of a Spatial Dose Pattern Associated with Radiation Pneumonitis in Patients Treated with Radiotherapy for a Locally Advanced Lung Cancer
por: Bourbonne, Vincent, et al.
Publicado: (2022)

Narrative Review of the Post-Operative Management of Prostate Cancer Patients: Is It Really the End of Adjuvant Radiotherapy?
por: Bourbonne, Vincent, et al.
Publicado: (2022)

Pembrolizumab plus pemetrexed-carboplatin combination in first-line treatment of advanced non-squamous non-small cell lung cancer: a multicenter real-life study (CAP29)
por: Renaud, Emmanuelle, et al.
Publicado: (2023)

Radiomics Approaches for the Prediction of Pathological Complete Response after Neoadjuvant Treatment in Locally Advanced Rectal Cancer: Ready for Prime Time?
por: Bourbonne, Vincent, et al.
Publicado: (2023)

Efficacy and Safety of a Second Course of Stereotactic Radiation Therapy for Locally Recurrent Brain Metastases: A Systematic Review
por: Lucia, François, et al.
Publicado: (2021)

A multi-omics supervised autoencoder for pan-cancer clinical outcome endpoints prediction
por: Tan, Kaiwen, et al.
Publicado: (2020)

Impact of concomitant systemic treatments on toxicity and intracerebral response after stereotactic radiotherapy for brain metastases
por: Guénolé, Morgan, et al.
Publicado: (2020)

Use of Baseline (18)F-FDG PET/CT to Identify Initial Sub-Volumes Associated With Local Failure After Concomitant Chemoradiotherapy in Locally Advanced Cervical Cancer
por: Lucia, François, et al.
Publicado: (2020)

Dosimetric Validation of a GAN-Based Pseudo-CT Generation for MRI-Only Stereotactic Brain Radiotherapy
por: Bourbonne, Vincent, et al.
Publicado: (2021)

Editorial: Multi-omics approaches for decoding heterogeneity in cancer immunotherapy
por: Jiang, Aimin, et al.
Publicado: (2023)

External Validation of a Radiomics Model for the Prediction of Complete Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer
por: Bordron, Anaïs, et al.
Publicado: (2022)

Real‐life second‐line epirubicin–paclitaxel regimen as treatment of relapsed small‐cell lung cancer: EpiTax study
por: Annic, Josselin, et al.
Publicado: (2022)

MRI-Derived Radiomics to Guide Post-operative Management for High-Risk Prostate Cancer
por: Bourbonne, Vincent, et al.
Publicado: (2019)

Impact of suboptimal dosimetric coverage of pretherapeutic 18F-FDG PET/CT hotspots on outcome in patients with locally advanced cervical cancer treated with chemoradiotherapy followed by brachytherapy
por: Lucia, François, et al.
Publicado: (2020)

Re-Irradiation by Stereotactic Radiotherapy of Brain Metastases in the Case of Local Recurrence
por: Touati, Ruben, et al.
Publicado: (2023)

Precision Medicine and Melanoma: Multi-Omics Approaches to Monitoring the Immunotherapy Response
por: Valenti, Fabio, et al.
Publicado: (2021)

New Automated Method for Lung Functional Volumes Delineation with Lung Perfusion PET/CT Imaging
por: Pinot, Fanny, et al.
Publicado: (2023)

Improved Endpoints for Cancer Immunotherapy Trials
por: Hoos, Axel, et al.
Publicado: (2010)

Radiomics Analysis of 3D Dose Distributions to Predict Toxicity of Radiotherapy for Cervical Cancer
por: Lucia, François, et al.
Publicado: (2021)

What is the ideal endpoint in early-stage immunotherapy neoadjuvant trials in lung cancer?
por: Cameron, Robert B., et al.
Publicado: (2023)

The Comprehensive “Omics” Approach from Metabolomics to Advanced Omics for Development of Immune Checkpoint Inhibitors: Potential Strategies for Next Generation of Cancer Immunotherapy
por: Yoon, Sang Jun, et al.
Publicado: (2021)

Consideration of Surrogate Endpoints for Overall Survival Associated With First-Line Immunotherapy in Extensive-Stage Small Cell Lung Cancer
por: Zhang, Shuang, et al.
Publicado: (2021)

Signatures of Multi-Omics Reveal Distinct Tumor Immune Microenvironment Contributing to Immunotherapy in Lung Adenocarcinoma
por: Huang, Ziqi, et al.
Publicado: (2021)

FDG PET and CT radiomics in diagnosis and prognosis of non-small-cell lung cancer
por: Hannequin, Pascal, et al.
Publicado: (2022)

Multi-omics approaches to disease
por: Hasin, Yehudit, et al.
Publicado: (2017)

Multi-omics prediction of immune-related adverse events during checkpoint immunotherapy
por: Jing, Ying, et al.
Publicado: (2020)

Multi-omics approaches for comprehensive analysis and understanding of the immune response in the miniature pig breed
por: Arora, Devender, et al.
Publicado: (2022)

A comprehensive survey of the approaches for pathway analysis using multi-omics data integration
por: Maghsoudi, Zeynab, et al.
Publicado: (2022)

Editorial: The role of multi-omics variants in tumor immunity and immunotherapy
por: Chen, Shuang, et al.
Publicado: (2022)

Toxicity in patients treated with permanent prostate brachytherapy using intraoperatively built custom-linked seeds versus loose seeds
por: Ollivier, Luc, et al.
Publicado: (2020)

Comprehensive multi-omics analysis reveals m7G-related signature for evaluating prognosis and immunotherapy efficacy in osteosarcoma
por: Zhang, Yiming, et al.
Publicado: (2023)

COTTONOMICS: a comprehensive cotton multi-omics database
por: Dai, Fan, et al.
Publicado: (2022)

Durvalumab‐induced lesions of bronchiolitis and fully reversible bronchiectasis in a patient with non‐small cell lung cancer: A case report
por: Domblides, Maël, et al.
Publicado: (2021)

Clinical endpoints in allergen immunotherapy: State of the art 2022
por: Gerth van Wijk, Roy, et al.
Publicado: (2023)

A Feasibility Study of Functional Lung Volume Preservation during Stereotactic Body Radiotherapy Guided by Gallium-(68) Perfusion PET/CT
por: Lucia, François, et al.
Publicado: (2023)

Development of a Radiomic-Based Model Predicting Lymph Node Involvement in Prostate Cancer Patients
por: Bourbonne, Vincent, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8d387tr1p1tq7rmdn5o6f7jg2q